| Long name: |
FITC Conjugated, BRWD3 Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
Anti-FITC Antibody |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
BRWD3 |
| Specificity: |
This is a highly specific antibody against BRWD3 |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic peptide derived from human BRWD3 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Mouse, Rat, Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
BRWD3 (bromodomain and WD repeat-containing protein 3) is a 1, BRWD3 contains two bromo domains, Existing as five alternatively spliced isoforms, MRX93 is characterized by mild intellectual disability, Mutations in the gene encoding BRWD3 are the cause of mental retardation X-linked type 93 (MRX93), a prominent forehead and large cupped ears, apoptosis and gene regulation, including cell cycle progression, macrocephaly, nine WD repeats and is thought to play a role in transcription by modifying chromatin, signal transduction, which is also known as mental retardation X-linked with macrocephaly (XLMR), 802 amino acid protein expressed in fetal liver and most adult tissues, Members of the WD repeat protein family are involved in a variety of cellular processes |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
494nm/518nm |
| Synonyms: |
FLJ38568 MRX93 |
| Properties: |
Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
BRWD3 Conjugated |
| Short name: |
FITC Conjugated, BRWD3 Antibody |
| Technique: |
Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
FITC |
| Alternative name: |
fluorecein coupled, BRWD3 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
17342 |
| Gene: |
BRWD3 |
More about : BRWD3 |
| Long gene name: |
bromodomain and WD repeat domain containing 3 |
| Locus: |
Xq21, 1 |
| Discovery year: |
2005-01-07 |
| Entrez gene record: |
254065 |
| Pubmed identfication: |
15543602 16094372 |
| RefSeq identity: |
NM_153252 |
| Classification: |
X-linked mental retardation WD repeat domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000021908 |
| Locus Specific Databases: |
Mental Retardation database |